Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein

By Liang X.   Munshi S.   Shendure J.   Mark G.   Davies M.E.   Freed D.C.   Montefiori D.C.   Shiver J.W.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2862-2872

Elsevier

Access to resources Recommend Favorite

Molecular basis of the inefficacy and possible harmful effects of AIDS vaccine candidates based on HIV-1 envelope glycoprotein gp120

By Veljkovic V.   Johnson E.   Metlas R.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 473-474

Elsevier

Access to resources Recommend Favorite

Efficient purification and rigorous characterisation of a recombinant gp120 for HIV vaccine studies

By Jones D.H.   McBride B.W.   Roff M.A.   Farrar G.H.  

Vaccine, Vol. 13, Iss. 11, 1995-01 ,pp. : 991-999

Elsevier

Access to resources Recommend Favorite

Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin

By Hajishengallis G.   Harokopakis E.   Hollingshead S.K.   Russell M.W.   Michalek S.M.  

Vaccine, Vol. 14, Iss. 16, 1996-11 ,pp. : 1545-1548

Elsevier

Access to resources Recommend Favorite

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

By Barnett S.W.   Rajasekar S.   Legg H.   Doe B.   Fuller D.H.   Haynes J.R.   Walker C.M.   Steimer K.S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 869-873

Elsevier

Access to resources Recommend Favorite